PCC Rokita Balance Sheet Health
Financial Health criteria checks 6/6
PCC Rokita has a total shareholder equity of PLN1.4B and total debt of PLN523.4M, which brings its debt-to-equity ratio to 37.9%. Its total assets and total liabilities are PLN2.5B and PLN1.1B respectively. PCC Rokita's EBIT is PLN378.4M making its interest coverage ratio 20.1. It has cash and short-term investments of PLN290.4M.
Key information
37.9%
Debt to equity ratio
zł523.38m
Debt
| Interest coverage ratio | 20.1x |
| Cash | zł290.41m |
| Equity | zł1.38b |
| Total liabilities | zł1.14b |
| Total assets | zł2.52b |
Recent financial health updates
Is PCC Rokita (WSE:PCR) Using Too Much Debt?
Aug 24
Is PCC Rokita (WSE:PCR) A Risky Investment?
Jan 18Is PCC Rokita (WSE:PCR) Using Too Much Debt?
Jan 15
Recent updates
Is PCC Rokita (WSE:PCR) Using Too Much Debt?
Aug 24PCC Rokita's (WSE:PCR) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 29Is PCC Rokita (WSE:PCR) A Risky Investment?
Jan 18PCC Rokita (WSE:PCR) Is Increasing Its Dividend To zł13.23
Apr 16Why We Like The Returns At PCC Rokita (WSE:PCR)
Mar 19What Is PCC Rokita SA's (WSE:PCR) Share Price Doing?
Jan 25We Like These Underlying Return On Capital Trends At PCC Rokita (WSE:PCR)
Sep 01Why PCC Rokita SA (WSE:PCR) Could Be Worth Watching
Jun 14Are PCC Rokita SA (WSE:PCR) Investors Paying Above The Intrinsic Value?
May 18Returns On Capital At PCC Rokita (WSE:PCR) Have Hit The Brakes
Apr 13Why PCC Rokita's (WSE:PCR) Earnings Are Better Than They Seem
Mar 23PCC Rokita SA's (WSE:PCR) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
Mar 09Looking For Steady Income For Your Dividend Portfolio? Is PCC Rokita SA (WSE:PCR) A Good Fit?
Feb 19What Does PCC Rokita SA's (WSE:PCR) Share Price Indicate?
Feb 04Is PCC Rokita (WSE:PCR) Using Too Much Debt?
Jan 15Should We Be Excited About The Trends Of Returns At PCC Rokita (WSE:PCR)?
Dec 30Reflecting on PCC Rokita's (WSE:PCR) Share Price Returns Over The Last Three Years
Dec 17PCC Rokita SA's (WSE:PCR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Dec 03Are Dividend Investors Getting More Than They Bargained For With PCC Rokita SA's (WSE:PCR) Dividend?
Nov 20Financial Position Analysis
Short Term Liabilities: PCR's short term assets (PLN797.2M) exceed its short term liabilities (PLN502.2M).
Long Term Liabilities: PCR's short term assets (PLN797.2M) exceed its long term liabilities (PLN641.3M).
Debt to Equity History and Analysis
Debt Level: PCR's net debt to equity ratio (16.9%) is considered satisfactory.
Reducing Debt: PCR's debt to equity ratio has reduced from 76.5% to 37.9% over the past 5 years.
Debt Coverage: PCR's debt is well covered by operating cash flow (97.8%).
Interest Coverage: PCR's interest payments on its debt are well covered by EBIT (20.1x coverage).